Director, Inflation Reduction Act Strategy & Planning

Director of IRA Navigation and Possibilities — business-critical role serving as subject matter expert to provide strategic direction and cross-functional leadership to proactively manage Inflation Reduction Act (IRA) risks and opportunities for current commercial brands and future pipeline products.

Key Responsibilities:
- Partner with Commercial Therapeutics, US Market Access, Global Commercial Development (GCD), Finance, Government Affairs, and Legal to assess IRA impacts on brands and pipeline assets.
- Serve as IRA subject matter expert for therapeutic area leaders, Integrated Brand Teams (IBTs), and Asset Strategy Teams (ASTs) on implementation implications/timelines and long-term impact.
- Develop and lead a framework to evaluate and risk-assess on-market and pipeline assets with IBTs and ASTs.
- Identify/prioritize IRA risks across the Long Range Plan (LRP) for each asset and lead mitigation strategies (life cycle management, negotiation alternatives, evidence generation).
- Support portfolio-wide risk stratification and segmentation.
- Drive solutions that minimize IRA risk and maximize opportunity for patients and AbbVie.

Qualifications:
- Bachelor’s degree in business or related discipline.
- Master’s degree highly desirable.
- 12+ years progressive experience in highly regulated commercial business; pharma/healthcare strongly preferred.

Preferred Qualifications:
- Advanced degree in life sciences, business, public policy, or related.
- Experience in portfolio risk management, market access, or strategic planning.
- Deep understanding of US healthcare policy/regulatory landscape; IRA knowledge valued.
- Leadership, cross-functional team leadership, strong communication/negotiation, analytical problem-solving.